Expert Review of Vaccines

Article	Citations
Impact of the Delta variant on vaccine efficacy and response strategies	180
COVID-19 vaccine hesitancy in South Africa: how can we maximize uptake of COVID-19 vaccines?	147
Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies	133
COVID-19 vaccine: where are we now and where should we go?	110
To mix or not to mix? A rapid systematic review of heterologous prime–boost covid-19 vaccination	85
DNA vaccines for SARS-CoV-2: toward third-generation vaccination era	78
ExploringKlebsiella pneumoniaecapsule polysaccharide proteins to design multiepitope subunit vaccine to fight against pneumonia	77
Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China	63
Nanovaccine: an emerging strategy	63
The emergence of new strains of SARS-CoV-2. What does it mean for COVID-19 vaccines?	62
COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies	61
Parental COVID-19 vaccine hesitancy: a cross-sectional survey in Italy	56
COVID-19 vaccines: concerns beyond protective efficacy and safety	56
Determinants of parental hesitancy to vaccinate their children against COVID-19 in China	55
Transmission-Blocking Vaccines: Harnessing Herd Immunity for Malaria Elimination	54
Social media strategies to affect vaccine acceptance: a systematic literature review	54
Inhaled vaccine delivery in the combat against respiratory viruses: a 2021 overview of recent developments and implications for COVID-19	52
Surveying willingness toward SARS-CoV-2 vaccination of healthcare workers in Italy	50
Global impact of delta plus variant and vaccination	48
COVID-19 vaccination in pregnant and lactating women: a systematic review	48
COVID-19 vaccine acceptance and hesitancy among healthcare workers in South Africa	48
CpG-Adjuvanted Hepatitis B Vaccine (HEPLISAV-B®) Update	47
Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China	41
From COVID-19 Vaccination Intention to Actual Vaccine Uptake: A Longitudinal Study Among Chinese Adults After Six Months of a National Vaccination Campaign	41
Vaccine hesitancy in health-care providers in Western countries: a narrative review	37

COVID-19 vaccination hesitancy in pregnant and breastfeeding women and strategies to increase vaccination compliance: a systematic review and meta-analysis	37
Chlamydia trachomatisvaccines for genital infections: where are we and how far is there to go?	36
COVID-19 vaccine equity: a health systems and policy perspective	36
Efficacy and effectiveness of a 23-valent polysaccharide vaccine against invasive and noninvasive pneumococcal disease and related outcomes: a review of available evidence	36
Clinical development and approval of COVID-19 vaccines	36
From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection	33
Microneedle Systems for Vaccine Delivery: the story so far	33
COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials	32
Expert review on global real-world vaccine effectiveness against SARS-CoV-2	32
COVID-19 and vaccination: myths vs science	32
COVID-19 vaccination hesitancy in Italian healthcare workers: a systematic review and meta-analysis	32
Thermostable vaccines: an innovative concept in vaccine development	31
Inequitable COVID-19 vaccine distribution and the intellectual property rights prolong the pandemic	31
Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic	31
The status of human papillomavirus vaccination recommendation, funding, and coverage in WHO Europe countries (2018–2019)	30
Vaccine development against Helicobacter pylori: from ideal antigens to the current landscape	28
Lifting non-pharmaceutical interventions following the COVID-19 pandemic – the quiet before the storm?	27
Herpes zoster and simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis	26
Emerging advances in synthetic cancer nano-vaccines: opportunities and challenges	26
Overcoming roadblocks in the development of vaccines for leishmaniasis	26
Real-world impact and effectiveness of the quadrivalent HPV vaccine: an updated systematic literature review	25
Vaccinomics: a future avenue for vaccine development against emerging pathogens	24
Reported adverse effects following COVID-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST)	24
A practitioner’s guide to the recombinant zoster vaccine: review of national vaccination recommendations	24
Examining the validity of the drivers of COVID-19 vaccination acceptance scale using Rasch analysis	24
Correlates of malaria vaccine efficacy	24
Disproportionate COVID-19 vaccine acceptance rate among healthcare professionals on the eve of nationwide vaccine distribution in Bangladesh	23
A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children	23
SARS-CoV-2 subunit vaccine adjuvants and their signaling pathways	23
COVID-19 vaccines and thrombosis with thrombocytopenia syndrome	23
Progress towards the development of a P. vivax vaccine	22
Influenza vaccine: progress in a vaccine that elicits a broad immune response	22
Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy	22
COVID-19 vaccine mandate for healthcare workers in the United States: a social justice policy	22
Overcoming COVID-19 vaccine hesitancy: can Australia reach the last 20 percent?	22
Gap between willingness and behavior in the vaccination against influenza, pneumonia, and herpes zoster among Chinese aged 50–69 years	22
Eradicating polio in Pakistan: a systematic review of programs and policies	21
Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations	21
Multi-functional antibody profiling for malaria vaccine development and evaluation	20
Challenges targeting cancer neoantigens in 2021: a systematic literature review	20
COVID-19 vaccine design and vaccination strategy for emerging variants	20
Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease	20
Global prevalence of acceptance of COVID-19 vaccines and associated factors in pregnant women: a systematic review and meta-analysis	20
Repeated vaccination and ‘vaccine exhaustion’: relevance to the COVID-19 crisis	20
Measles, mumps, rubella prevention: how can we do better?	20
The challenges of a circumsporozoite protein-based malaria vaccine	19
Use of lentiviral vectors in vaccination	19
Immunization coverage among asplenic patients and strategies to increase vaccination compliance: a systematic review and meta-analysis	18
Parental knowledge about respiratory syncytial virus (RSV) and attitudes to infant immunization with monoclonal antibodies	18
GMMA as a ‘plug and play’ technology to tackle infectious disease to improve global health: context and perspectives for the future	18

Synergistic activity of antibodies in the multicomponent 4CMenB vaccine	18
Immunoinformatics-guided designing and in silico analysis of epitope-based polyvalent vaccines against multiple strains of human coronavirus (HCoV)	18
Who is more likely to hesitate to accept COVID-19 vaccine: a cross-sectional survey in China	17
Seasonal influenza vaccine hesitancy profiles and determinants among Chinese children’s guardians and the elderly	17
Comparing reactogenicity of COVID-19 vaccines: a systematic review and meta-analysis	17
Recent advances in lipopolysaccharide-based glycoconjugate vaccines	17
Non-COVID-19 vaccine hesitancy among migrant populations worldwide: a scoping review of the literature, 2000-2020	17
Vaccine development against methamphetamine drug addiction	16
Understanding COVID-19 vaccine acceptance in Pakistan: an echo of previous immunizations or prospect of change?	16
Drivers of hesitancy towards recommended childhood vaccines in African settings: a scoping review of literature from Kenya, Malawi and Ethiopia	16
Efficacy and safety of influenza vaccination during pregnancy: realizing the potential of maternal influenza immunization	16
The rationale for use of clinically defined outcomes in assessing the impact of pneumococcal conjugate vaccines against pneumonia	15
Vaccines against leishmaniasis: using controlled human infection models to accelerate development	15
Structural vaccinology of malaria transmission-blocking vaccines	15
Recommendations to drive a value-based decision-making on vaccination	15
Quantification methods for viruses and virus-like particles applied in biopharmaceutical production processes	15
Bacterial biofilm-derived antigens: a new strategy for vaccine development against infectious diseases	15
The epidemiologic and biologic basis for classifying older age as a high-risk, immunocompromising condition for pneumococcal vaccine policy	15
COVID-19 vaccine coverage, concerns, and preferences among Chinese ICU clinicians: a nationwide online survey	15
Monkeypox: a new face of outbreak	15
Immunoinformatics driven construction of multi-epitope vaccine candidate against Ascaris lumbricoides using its entire immunogenic epitopes	15
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data	15
Vaccination strategies between compulsion and incentives. The Italian Green Pass experience	15
Reactogenicity and immunogenicity of BNT162b2 or mRNA-1273 COVID-19 booster vaccinations after two doses of BNT162b2 among healthcare workers in Japan: a prospective observational study	14
The race for a COVID-19 vaccine: where are we up to?	14
Why METH users are at high risk of fatality due to COVID-19 infection?	14
Evaluating the relationship between myocarditis and mRNA vaccination	14
Association of COVID-19 vaccination with herpes zoster: a systematic review and meta-analysis	14
Real-world implementation of 4-component meningococcal serogroup B vaccine (4CMenB): implications for clinical practices	14
Progress and new horizons toward a VAR2CSA-based placental malaria vaccine	14
Immune Response and Safety of Viral Vaccines in Children with Autoimmune Diseases on Immune Modulatory Drug Therapy	14
Immunogenicity following revaccination or sequential vaccination with 23-valent pneumococcal polysaccharide vaccine (PPSV23) in older adults and those at increased risk of pneumococcal disease: a revi	14
Development of thermostable vaccine adjuvants	13
Antibody response to the first dose of AZD1222 vaccine in COVID-19 convalescent and uninfected individuals in Bangladesh	13
Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines	13
The next major emergent infectious disease: reflections on vaccine emergency development strategies	13
Cardiovascular safety of COVID-19 vaccines in real-world studies: a systematic review and meta-analysis	13
Hepatitis E should be a global public health priority: recommendations for improving surveillance and prevention	13
Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine	13
Ensuring quality and integrity of vaccines throughout the cold chain: the role of temperature monitoring	13
Hypothetical emergence of poliovirus in 2020: part 1. Consequences of policy decisions to respond using nonpharmaceutical interventions	13
Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalization: a systematic review and meta-analysis	13
Delays in routine childhood vaccinations and their relationship with parental vaccine hesitancy: a cross-sectional study in Wuxi, China	12
From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global access	12
Cancer vaccines as a targeted immunotherapy approach for breast cancer: an update of clinical evidence	12
Immune to addiction: how immunotherapies can be used to combat methamphetamine addiction	12
The baculovirus expression vector system: a modern technology for the future of influenza vaccine manufacturing	12
Self-controlled case series design in vaccine safety: a systematic review	12
Effects of the COVID-19 pandemic on routine pediatric vaccination in Brazil	12
Hypothetical emergence of poliovirus in 2020: part 2. exploration of the potential role of vaccines in control and eradication	12
Quadrivalent influenza vaccine (Sinovac Biotech) for seasonal influenza prophylaxis	12
Carbohydrate-containing nanoparticles as vaccine adjuvants	12
Sporozoite immunization: innovative translational science to support the fight against malaria	12
Looking to the future: is a universal coronavirus vaccine feasible?	12
Insight into the current Toxoplasma gondii DNA vaccine: a review article	12
Rotavirus vaccines performance: dynamic interdependence of host, pathogen and environment	11
Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines	11
Cost-effectiveness of pneumococcal vaccines among adults over 50 years old in low- and middle-income countries: a systematic review	11
An instrument to measure psychosocial determinants of health care professionals’ vaccination behavior: Validation of the Pro-VC-Be questionnaire	11
Effectiveness of mRNA, protein subunit vaccine and viral vectors vaccines against SARS-CoV-2 in people over 18 years old: a systematic review	11
Dendritic cell-based vaccine: the state-of-the-art vaccine platform for COVID-19 management	11
Mucosal vaccination: onward and upward	11
‘Vaccinate my village’ strategy in Malawi: an effort to boost COVID-19 vaccination	11
Current vaccine approaches and emerging strategies against herpes simplex virus (HSV)	11
Emergence of mRNA vaccines in the management of cancer	11
Cost-effectiveness analysis for PCV13 in adults 60 years and over with underlying medical conditions which put them at an elevated risk of pneumococcal disease in Japan	11
Current understandings of the impact of mandatory vaccination laws in Europe	11
Identifying novel candidates and configurations for human helminth vaccines	11
Glycoconjugate vaccines against antimicrobial resistant pathogens	11
Public health impact of pneumococcal conjugate vaccination: a review of measurement challenges	10
Vaccine for a neglected tropical disease Taenia solium cysticercosis: fight for eradication against all odds	10
Mechanisms of cellular and humoral immunity through the lens of VLP-based vaccines	10
Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance	10
Will the mRNA vaccine platform be the panacea for the development of vaccines against antimicrobial resistant (AMR) pathogens?	10
Additional considerations for anti-tick vaccine research	10
Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks	10
Vaccination coverage rates and attitudes towards mandatory vaccinations among healthcare personnel in tertiary-care hospitals in Greece	10
Predicting the risk of severe COVID-19 outcomes in primary care: development and validation of a vulnerability index for equitable allocation of effective vaccines	10
Effectiveness of on-site influenza vaccination strategy in Italian healthcare workers: a systematic review and statistical analysis	10
Current development of Zika virus vaccines with special emphasis on virus-like particle technology	10

Reduced mother-to-child transmission of hepatitis B after implementation of completely charge-free active-passive immunoprophylaxis: an observational cohort study	10
Chlamydia trachomatisvaccine development – a view on the current challenges and how to move forward	10
COVID-19 vaccination and mask wearing behaviors in the United States, August 2020 - June 2021	10
Dendritic cell vaccine as a potential strategy to end the COVID-19 pandemic. Why should it be Ex Vivo?	10
Profile of respiratory syncytial virus prefusogenic fusion protein nanoparticle vaccine	10
Vaccines against SARS-CoV-2 variants and future pandemics	10
Improving pandemic preparedness through better, faster influenza vaccines	10
CIRCULATING CLONAL COMPLEXES AND SEQUENCE TYPES OF STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A WORLDWIDE: THE IMPORTANCE OF MULTIDRUG RESISTANCE: A SYSTEMATIC LITERATURE REVIEW	10
Should we be vaccinating children against COVID-19 in high-income countries?	10
Type I and II interferons toward ideal vaccine and immunotherapy	9
Preferences for herpes zoster vaccination among adults aged 50 years and older in the United States: results from a discrete choice experiment	9
Analysis of the coverage of inactivated enterovirus 71 (EV71) vaccine and adverse events following immunization with the EV71 vaccine among children from 2016 to 2019 in Guangzhou	9
Resilience learning from the COVID-19 pandemic and its relevance for routine immunization programs	9
Development of neoantigens: from identification in cancer cells to application in cancer vaccines	9
Lymphatic filariasis vaccine development: neglected for how long?	9
Clinical, economic, and humanistic burden of community acquired pneumonia in Europe: a systematic literature review	9
Making COVID-19 mRNA vaccines accessible: challenges resolved	9
A review of rotavirus vaccine use in Asia and the Pacific regions: challenges and future prospects	9
Public preferences and willingness to accept a hypothetical vaccine to prevent a pandemic in Japan: a conjoint analysis	9
The current and future role of nanovaccines in HIV-1 vaccine development	9
Matching-adjusted indirect comparison of pneumococcal vaccines V114 and PCV20	9
Correlates of protection for meningococcal surface protein vaccines: lessons from the past	9
Vaccination coverage among health-care workers: pre–post intervention study to assess impact of an on-site vaccination-dedicated clinic	9
Economic evaluations of 13-valent pneumococcal conjugate vaccine: a systematic review	9
Influence of social media on the public perspectives of the safety of COVID-19 vaccines	9
Thirty years of recombinant BCG: new trends for a centenary vaccine	9
In 30 years, gender-neutral vaccination eradicates oncogenic human papillomavirus (HPV) types while screening eliminates HPV-associated cancers	8
Adverse events reported after administration of BNT162b2 and mRNA-1273 COVID-19 vaccines among hospital workers: a cross-sectional survey-based study in a Spanish hospital	8
Clinical development of variant-adapted BNT162b2 COVID-19 vaccines: the early Omicron era	8
The associations of geographic location and perceived risk of infection with the intentions to get vaccinated against COVID-19 in China	8
Successes of the CDC monitoring systems in evaluating post-authorization safety of COVID-19 vaccines	8
Vaccine approaches for antigen capture by liposomes	8
Understanding the mechanisms for COVID-19 vaccine’s protection against infection and severe disease	8
Construction of a multiepitope vaccine candidate against Fasciola hepatica : an in silico design using various immunogenic excretory/secre	8
Real-world impact of rotavirus vaccination in European healthcare settings: a systematic literature review	8
Real-world impact and effectiveness assessment of the quadrivalent HPV vaccine: a systematic review of study designs and data sources	8
Update on CVD 103-HgR single-dose, live oral cholera vaccine	8
Next generation live-attenuated influenza vaccine platforms	8
Development of a recombinant vaccine against human onchocerciasis	8
Recent strategies driving oral biologic administration	7
Novel approaches to reactivate pertussis immunity	7
Where are we and how far is there to go in the development of anAcinetobactervaccine?	7
Health economic analysis of vaccine options for the polio eradication endgame: 2022-2036	7
Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2	7
Controlled human infection models to evaluate schistosomiasis and hookworm vaccines: where are we now?	7
Influenza B virus neuraminidase: a potential target for next-generation vaccines?	7
Strategies to increase uptake of maternal pertussis vaccination	7
Is SARS-CoV-2 vaccination safe and effective for elderly individuals with neurodegenerative diseases?	7
Chlamydia trachomatis: quest for an eye-opening vaccine breakthrough	7
The omics strategy: the use of systems vaccinology to characterize immune responses to childhood immunization	7
International adaptation and validation of the Pro-VC-Be: measuring the psychosocial determinants of vaccine confidence in healthcare professionals in European countries	7
A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom	7
A scoping review of literature exploring factors affecting vaccine uptake within Roma communities across Europe	7
Predicting effectiveness of the V114 vaccine against invasive pneumococcal disease in children	7
Systematic review and meta-analysis of HPV vaccination in women with systemic lupus erythematosus (SLE)	7
A novel vaccine to prevent meningococcal disease beyond the first year of life: an early review of MenACYW-TT	7
Latin American forum on immunization services during the COVID-19 pandemic	7
Efficacy and effectiveness of covid-19 vaccine - absolute vs. relative risk reduction	7
Adverse events following influenza immunization: understanding the role of age and sex interactions	7
A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK	7
Multi-criteria decision analysis to prioritize the introduction of new vaccines in Indonesia by using the framework of the strategic multi-attribute ranking tool for vaccines (SMART vaccines)	7
B cell targeting by molecular adjuvants for enhanced immunogenicity	7
The potential of intrinsically disordered regions in vaccine development	6
Immunization and Drug Metabolizing Enzymes: Focus on Hepatic Cytochrome P450 3A	6
A comprehensive review of clinical and real-world safety data for the four-component serogroup B meningococcal vaccine (4CMenB)	6
4CMenB vaccine and its role in preventing transmission and inducing herd immunity	6
A review of the DTaP-IPV-HB-PRP-T Hexavalent vaccine in pediatric patients	6
Comparative assessment of myocarditis and pericarditis reporting rates related to mRNA COVID-19 vaccines in Europe and the United States	6
Is vaccination necessary for COVID-19 patients? A retrospective cohort study investigating reinfection rates and symptomatology in a tertiary hospital	6
Research progress on substitution of in vivo method(s) by in vitro method(s) for human vaccine potency assays	6
Harnessing liver-resident memory T cells for protection against malaria	6
Safety of live attenuated influenza vaccine (LAIV) in children and adults with asthma: a systematic literature review and narrative synthesis	6
Progress in research on the S protein as the target of COVID-19 vaccines	6
Efficacy and safety of hepatitis B vaccine: an umbrella review of meta-analyses	6
A China-developed adenovirus vector-based COVID-19 vaccine: review of the development and application of Ad5-nCov	6
What are the challenges faced by COVID-19 vaccines?	6
Adjuvanted versus non-adjuvanted standard-dose influenza vaccines in preventing all-cause hospitalizations in the elderly: a cohort study with nested case-control analyses over 18 influenza seasons	6
Cost-effectiveness of use of 20-valent pneumococcal conjugate vaccine among adults in Germany	6
Translating meningococcal serogroup B vaccines for healthcare professionals	6
Budget impact analysis of introducing a non-reconstituted, hexavalent vaccine for pediatric immunization in the United Kingdom	6
Plasmodiuminfection and drug cure for malaria vaccine development	6
The need for pertussis vaccination among older adults and high-risk groups: a perspective from advanced economies of the Asia Pacific region	6
Use of Cost-Effectiveness Analyses for Decisions About Vaccination Programs for Meningococcal Disease in the United States, United Kingdom, The Netherlands, and Canada	6
Impact of a two-dose varicella immunization program on the incidence of varicella: a multi-year observational study in Shanghai, China	6
Hexavalent vaccines in infants: a systematic literature review and meta-analysis of the solicited local and systemic adverse reactions of two hexavalent vaccines	6
COVID-19 vaccines approved in the European Union: current evidence and perspectives	6
In-depth review of delivery carriers associated with vaccine adjuvants: current status and future perspectives	6
Reverse engineering approach: a step towards a new era of vaccinology with special reference to Salmonella	6
The road to achieving herd immunity: factors associated with Singapore residents’ uptake and hesitancy of the COVID-19 vaccination	6
SARS-CoV-2 the ASIA virus (Autoimmune/autoinflammatory Syndrome Induced by Adjuvants), the risk of infertility and vaccine hesitancy	6
Measuring psychosocial determinants of vaccination behavior in healthcare professionals: validation of the Pro-VC-Be short-form questionnaire	6
The broader impacts of otitis media and sequelae for informing economic evaluations of pneumococcal conjugate vaccines	5
No association between enterovirus 71 (EV71) vaccination and risk of febrile seizures: a population-based near real-time surveillance study	5
Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant	5
Monkeypox pandemic containment: does the ACAM2000 vaccine play a role in the current outbreaks?	5